Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | CASP1 | P29466 | 3/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | CD44 | P16070 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30839804 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL29683594 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL6011489 | 0.86 | CYP3A4 (0.50) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL29103604 | 0.86 | ALDH1A1 (0.43) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL31661352 | 0.85 | PLA2G7 (0.58) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL3785048 | 0.85 | PLA2G7 (0.58) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL3789437 | 0.84 | ALDH1A1 (0.54) | CYP3A4TSHRALDH1A1CASP1PDE10A | |
| SCHEMBL186969 | 0.84 | ALDH1A1 (0.48) | CYP3A4TSHRPIK3CAALDH1A1CASP1 | |
| SCHEMBL8146041 | 0.81 | ALDH1A1 (0.54) | CYP3A4TSHRALDH1A1CASP1PDE10A | |
| SCHEMBL2206282 | 0.81 | CYP3A4 (0.72) | CYP3A4TSHRPIK3CAALDH1A1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015454-A1 | HIGH PERFORMANCE, AMBIENT CURE POLYURETHANES COMPRISING POLYCAPROLACTONE POLYOLS | INGEVITY UK LTD (GB) | 2026-01-15 | — | — | US | claimed |
| EP-4594381-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | Ingevity UK Ltd (GB) | 2025-08-06 | — | — | EP | claimed |
| US-20250243313-A1 | POLYCAPROLACTONE POLYOLS, ELASTOMERS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-31 | — | — | US | claimed |
| WO-2025149744-A1 | POLYCAPROLACTONE POLYOLS, POLYURETHANE DISPERSIONS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-17 | — | — | WO | claimed |
| US-20250230274-A1 | POLYCAPROLACTONE POLYOLS, POLYURETHANE DISPERSIONS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-17 | — | — | US | claimed |
| US-20240110002-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD (GB) | 2024-04-04 | — | — | US | claimed |
| WO-2024068129-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD. (GB) | 2024-04-04 | — | — | WO | claimed |
| US-20260015454-A1 | HIGH PERFORMANCE, AMBIENT CURE POLYURETHANES COMPRISING POLYCAPROLACTONE POLYOLS | INGEVITY UK LTD (GB) | 2026-01-15 | — | — | US | disclosed |
| EP-4594381-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | Ingevity UK Ltd (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250243313-A1 | POLYCAPROLACTONE POLYOLS, ELASTOMERS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-31 | — | — | US | disclosed |
| US-20250230274-A1 | POLYCAPROLACTONE POLYOLS, POLYURETHANE DISPERSIONS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-17 | — | — | US | disclosed |
| WO-2025149744-A1 | POLYCAPROLACTONE POLYOLS, POLYURETHANE DISPERSIONS, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2025-07-17 | — | — | WO | disclosed |
| CN-120092033-A | Novel polyurethane or polyurethane-urea compositions with enhanced low temperature properties | 英格维蒂英国有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20240110002-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD (GB) | 2024-04-04 | — | — | US | disclosed |
| WO-2024068129-A1 | NOVEL POLYURETHANE OR POLYURETHANE-UREA COMPOSITION WITH ENHANCED LOW TEMPERATURE PERFORMANCE | INGEVITY UK LTD. (GB) | 2024-04-04 | — | — | WO | disclosed |
| US-20230331927-A1 | POLYMETALLOXANE-CONTAINING COMPOSITION, CURED BODY, MEMBER, ELECTRONIC COMPONENT, AND FIBER | TORAY INDUSTRIES, INC. (JP) | 2023-10-19 | — | — | US | disclosed |
| US-20210139390-A1 | PRODUCTION METHOD OF ORGANIC COMPOUND | UNITIKA LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3819283-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | Unitika Ltd. (JP) | 2021-05-12 | — | — | EP | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015454-A1 | HIGH PERFORMANCE, AMBIENT CURE POLYURETHANES COMPRISING POLYCAPROLACTONE POLYOLS | PUF60, MORF4L1, C9 | CYP3A4 1622/4885TSHR 4502/4885PIK3CA 2165/4885 |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CYP3A4 177/4885TSHR 1688/4885PIK3CA 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.